RxDoctor Payments Data

Suketu Patel, MD

Radiation Oncology · Perrysburg, OHNPI 1912326877

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (44.3%), travel and lodging and consulting fees — rather than concentrated in one kind of arrangement. 12 manufacturers reported payments, led by Boston Scientific at 36.5% of the total. Reporting peaked in 2019 at $1,097 and has fallen 89.1% since, to $119 in 2025.

$2,424in general payments, 2019–2025

Across 23 payments — averaging $105.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boston Scientific$885
  • AstraZeneca$609
  • Merck$176
  • Blue Earth Diagnostics$176
  • Bayer$122
  • Novocure Inc.$121
  • plus $336 from 6 others

What the payments were for

  • Consulting fees$52522%
  • Speaking & faculty fees$422%
  • Travel & lodging$78332%
  • Food & beverage$1,07444%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,424 in reported general payments places this provider in the 80th percentile of 255 radiation oncology providers in Ohio.

See all radiation oncology providers in Ohio →

Medicare billing

Part B allowed, 2024
$151,248
Medicare patients
200
Services billed
1,608

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Betamethasone Valerate33$908
Tamsulosin Hcl67$829
Lidocaine Hcl ViscousLidocaine Hcl13$280
Fluconazole15$188
Oxybutynin Chloride ErOxybutynin Chloride13$163
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen11$121
Levothyroxine Sodium16$80
Dexamethasone13$73

Paid to pharmacies, not to this prescriber.

Other radiation oncology in Perrysburg

See the full list for Ohio →

Where these figures come from

Is this you, or does something look wrong? →